The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Device related sepsis 4
RITUXIMAB Disease recurrence 4
Rituximab Disseminated intravascular coagulation 4
RITUXIMAB Drug effect decreased 4
Rituximab Escherichia bacteraemia 4
Rituximab Eye pain 4
Rituximab Flushing 4
RITUXIMAB Gastric haemorrhage 4
RITUXIMAB H1N1 influenza 4
RITUXIMAB Haemoglobin decreased 4
RITUXIMAB Hepatocellular carcinoma 4
Rituximab Hyperbilirubinaemia 4
RITUXIMAB Hyperglycaemia 4
RITUXIMAB Hyperreflexia 4
Rituximab Infectious colitis 4
RITUXIMAB Invasive lobular breast carcinoma 4
Rituximab Lentigo 4
RITUXIMAB Leukocytosis 4
Rituximab Liver function test abnormal 4
Rituximab Lymphoedema 4

Total Records: 1,104     Number of Pages: 56